申请人:SyntheX, Inc.
公开号:US10188691B2
公开(公告)日:2019-01-29
The present disclosure provides methods to treat conditions, including cancer, using compounds that can target resistant cancer cells. The compounds can be used to sensitize resistant cancer cells or decrease the proliferation of cells. The compounds can target proteins in the DNA damage repair pathway leading to a decrease in DNA damage repair in target cells.
本公开提供了使用可靶向抗药性癌细胞的化合物治疗包括癌症在内的各种疾病的方法。这些化合物可用于敏化抗药性癌细胞或减少细胞增殖。这些化合物可以靶向 DNA 损伤修复途径中的蛋白质,从而导致靶细胞中 DNA 损伤修复的减少。